Image test
Critical Commentary
pece_annotation_1473112109
Sara.TillThis report provides a detailed analysis of international response to nuclear emergencies. In addition to reviewing historic nuclear emergencies and their responses, it examines current nuclear policies. Initial reactions to previous nuclear emergencies (Chernobyl, Three Mile Island, ect.) focused on preventing future incidents. Yet, Dr. Schmid argues increased safety measures and rigorous regulation cannot possibly safeguard against all emergency scenarios. She emphasizes the need to create an international organization to serve as an emergent response team, and explores several candidates such as the International Atomic Energy Agency and World Association of Nuclear Operators. However, Dr. Schmid concludes none of these suggested organizations currently have the fiscal capability or internation authority to act in this role.
pece_annotation_1480862436
Sara.TillAs I mentioned in earlier answers, at the peak of the crack-cocaine epidemic, BSVAC was founded (1988). It took outside EMS agencies an average of 30 minutes to reach patients with Bed-Stuy, a time that is far too costly for major trauma patients. This causes the current Commander (formerly referred to as Captain) "Rocky" Robinson to begin a volunteer EMS agency within the city itself. Placing the agency in the city decreased response time significantly, with BSVAC now averaging a response time of less than 4 minutes.
pece_annotation_1473627670
Sara.TillPaul Farmer: American anthropologist and physician best known for his work combating tuberculosis in developing countries. Co-founder of Partners in Health, an organization dedicated to establishing and developing health care systems in under-served areas.
Bruce Nizeye: Engineer who works with Partners in Health directing the building program. Rwandese by birth and survivor of the Rwanda Genocide.
Sara Stulac: Associate physicain in Global Health Equity at Brigham and Women's hospital. Clinical Director for PIH in Rwanda
Salmaan Keehavjee: Associate professor of global health and science medicine at Harvard Medical School. Specializes in tuberculosis research and proliferation.
Doloremque diamlorem incidunt, repellendus expedita?